NATU3:BMFBOVESPANatura Cosmeticos SA Analysis
Data as of 2026-05-18 - not real-time
R$10.04
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading above its short‑term and mid‑term moving averages, reinforcing a bullish bias. Volume is on an upward trend, the relative strength index sits near the neutral zone, and the MACD histogram, while still negative, is narrowing, suggesting that bearish momentum may be fading. Valuation pressure: A discounted cash flow model indicates a fair value well above the current market price, pointing to a sizable upside potential.
Fundamental backdrop: Recent earnings are negative, yet forward earnings estimates are positive, delivering a low forward price‑to‑earnings multiple. The price‑to‑book ratio hovers around one, free cash flow is solid, and debt levels are moderate for the sector. The company operates in a consumer‑defensive segment with strong brand presence across several Latin American markets, but it does not pay a dividend and faces typical regulatory and currency considerations.
Fundamental backdrop: Recent earnings are negative, yet forward earnings estimates are positive, delivering a low forward price‑to‑earnings multiple. The price‑to‑book ratio hovers around one, free cash flow is solid, and debt levels are moderate for the sector. The company operates in a consumer‑defensive segment with strong brand presence across several Latin American markets, but it does not pay a dividend and faces typical regulatory and currency considerations.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price above key moving averages
- support level intact
- increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside relative to market price
- positive forward earnings outlook
- strong free cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- defensive consumer segment positioning
- expanding brand footprint in Latin America
- sustainable cash flow despite short‑term earnings volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-7.30%
Profit Margin-8.18%
P/E Ratio8.5
ROE4.77%
ROA4.52%
Debt/Equity52.16
P/B Ratio1.1
Op. Cash FlowR$-114984000
Free Cash FlowR$2.0B
Technical Analysis
TrendBullish
RSI49.0
SupportR$9.17
ResistanceR$11.15
MA 20R$10.19
MA 50R$9.85
MA 200R$8.87
MACDBearish
VolumeIncreasing
Fear & Greed Index88.73
Valuation
Fair ValueR$16.67
Target PriceR$12.39
Upside/Downside23.43%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.90
Volatility28.68%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.